CIK 0001490978 · Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954284541
- Phone
- 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,781,663
- in 3 filings, $2.8M under 10b5-1 plans
Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | GINSBERG GARY L Director | Grant or award · Stock Option (right to buy) | +8,550 | 8,550 | ||
| 2024-03-21 | Abel Robert Lorne See Remarks | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-03-21 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-03-06 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Option exercise | +5,574 | $4.34 | $24K | 42,061 |
| 2024-03-06 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Option exercise · Stock Option (right to buy) | −5,574 | 0 | ||
| 2024-03-04 | Porges Geoffrey Craig EVP & CFO | Grant or award | +9,000 | 9,000 | ||
| 2024-03-04 | Porges Geoffrey Craig EVP & CFO | Sale | −3,315 | $26.35 | $87K | 5,685 |
| 2024-03-04 | Porges Geoffrey Craig EVP & CFO | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2024-03-04 | Farid Ramy President & CEO | Grant or award · Stock Option (right to buy) | +126,000 | 126,000 | ||
| 2024-03-04 | Farid Ramy President & CEO | Grant or award · Stock Option (right to buy) | +87,271 | 87,271 | ||
| 2024-03-04 | Herman Jenny SVP & Controller | Grant or award | +7,313 | 19,074 | ||
| 2024-03-04 | Herman Jenny SVP & Controller | Grant or award · Stock Option (right to buy) | +14,625 | 14,625 | ||
| 2024-03-04 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-03-04 | Akinsanya Karen President of R&D, Therapeutics | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2024-03-04 | Tran Yvonne EVP, CLO & CPO | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-03-04 | Dugan Margaret Chief Medical Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-03-04 | Abel Robert Lorne See Remarks | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-02-12 | Tran Yvonne EVP, CLO & CPO | Sale 10b5-1 | −758 | $28.29 | $21K | 11,963 |
| 2024-02-12 | Abel Robert Lorne See Remarks | Sale 10b5-1 | −1,205 | $27.55 | $33K | 9,340 |
| 2024-02-12 | Herman Jenny SVP & Controller | Sale 10b5-1 | −787 | $28.29 | $22K | 11,761 |
Page 9 of 11 · 214 trades